DICE NASDAQ
DICE Therapeutics, Inc.
1W: +0.0%
1M: +1.7%
3M: +45.0%
1Y: +143.0%
$47.55
Last traded 2023-08-18 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$0
-100.0% ▼
Gross Profit
$0
-100.0% ▼
Operating Income
-$88M
-85.3% ▼
Net Income
-$82M
-68.5% ▼
EPS (Diluted)
$-2.07
+47.1% ▲
EBITDA
-$83M
-74.9% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|
| Revenue | $6M | $863K | $1M | $0 |
| YoY Growth | +0.0% | -85.1% | +30.4% | -100.0% |
| Cost of Revenue | $0 | $0 | $0 | $0 |
| Gross Profit | $6M | $863K | $1M | $0 |
| Gross Margin | 100.0% | 100.0% | 100.0% | — |
| R&D Expenses | $16M | $20M | $37M | $63M |
| SG&A Expenses | $4M | $5M | $12M | $26M |
| Operating Expenses | $19M | $25M | $49M | $88M |
| Operating Income | -$14M | -$24M | -$48M | -$88M |
| Operating Margin | -234.6% | -2748.7% | -4231.4% | — |
| Interest Expense | $26K | $13K | $174K | $679K |
| Income Before Tax | -$13M | -$24M | -$49M | -$84M |
| Tax Expense | $26K | $13K | -$487K | -$2M |
| Net Income | -$13M | -$24M | -$48M | -$82M |
| Net Margin | -224.5% | -2752.3% | -4308.6% | — |
| EPS (Diluted) | $-0.56 | $-1.02 | $-3.91 | $-2.07 |
| EBITDA | -$12M | -$23M | -$49M | -$83M |
| Shares Outstanding | 23M | 23M | 12M | 39M |